Skip to main content

Journal of Pharmaceutical Policy & Practice transfers to Taylor & Francis

Starting January 1, 2024, Journal of Pharmaceutical Policy & Practice is publishing with Taylor & Francis. Authors wishing to submit a new paper to the journal must submit their work via submission system at Taylor & Francis. All JoPPP publications (past and present) will be available on the Taylor & Frances website starting January 2024.

JoPPP receives first impact factor

We are excited to announce that the journal has received its first impact factor in Web of Science. Read more here.

Announcing the 2023 Helen Clark-JoPPP Award Winners

We are pleased to announce the winners of the 2023 Helen-Clark-JoPPP Award for Pharmaceutical Policy and Practice Research: 

Professor Cha-oncin Sooksriwong, Thammasat University, Thailand
Dr. Suzete Costa, Institute for Evidence-Based Health (ISBE), Portugal
Professor Dato’ Abu Bakar Abdul Majeed, UiTM Malaysia

They are being presented with the award based on the scientific merit of their work, as well as the impact of their work on patients, decision-makers and governments. Learn more about this year’s winners here.

Aims and scope

Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) provides a platform for researchers to disseminate empirical research findings with the aim that people everywhere have access to the medicines they need and be able to use them rationally.

The Journal encompasses all aspects of pharmacy including clinical, social, administration, and economics. It also covers pharmaceutical aspects of healthcare policy, providing a platform to researchers, academics and practitioners from around the world to share evidence, concerns and perspectives on pharmacy systems, management, ethics, and financial analysis.


  1. Authors: Ali Elbeddini, Thulasika Prabaharan, Sarah Almasalkhi and Cindy Tran

About the Editor

Zaheer-Ud-Din Babar is Professor in Medicines and Healthcare at the Department of Pharmacy, University of Huddersfield, United Kingdom.

He is globally recognized for his research in pharmaceutical policy and practice, including the quality use of medicines, clinical pharmacy practice, access to medicines and issues related to pharmacoeconomics. Previously he was the Head of Pharmacy Practice at School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, New Zealand. A pharmacist by training and a Ph.D. in pharmacy practice, Prof. Babar is the recipient of prestigious “Research Excellence Award” from the University of Auckland.

Journal History

In December 2008, Southern Med Review was started by Prof. Zaheer Babar to promote pharmaceutical policy research at a global level. The journal has been unique in publishing the work of new researchers, documenting the pharmaceutical situation of low- and middle-income countries and debating pertinent pharmaceutical policy questions. The journal's work has been recognized at a global level and, according to WHO, it fulfilled a global need. The journal is indexed in Scopus, EMBASE and PubMed Central and in 2013 has been relaunched as Journal of Pharmaceutical Policy and Practice by BioMed Central.

Archival content

An electronic archive of content under the journal's previous name Southern Med Review (2009-2012) can be found on PubMed Central.

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2023 Usage
    963 Altmetric mentions